Selected research
Industry Growth & Trends
Global Cyanocobalamin Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Cyanocobalamin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cyanocobalamin Injection include ANGELINI, Bayer HealthCare, Biological E, Bristol-Myers Squibb, CCEPCD, Endo International, Huaxin Pharmaceutical, Jamieson and Luitpold Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cyanocobalamin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cyanocobalamin Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyanocobalamin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyanocobalamin Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cyanocobalamin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cyanocobalamin Injection Market by Company
ANGELINI
Bayer HealthCare
Biological E
Bristol-Myers Squibb
CCEPCD
Endo International
Huaxin Pharmaceutical
Jamieson
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Sanofi-Aventis
Pfizer
Mylan
Merck
Teva (Actavis)
Cyanocobalamin Injection Segment by Type
Vitamins
Supplements
Cyanocobalamin Injection Segment by Application
Hospitals
Clinics
Others
Cyanocobalamin Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cyanocobalamin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamins
- Supplements
Applications
- Hospitals
- Clinics
- Others
Companies covered
- ANGELINI
- Bayer HealthCare
- Biological E
- Bristol-Myers Squibb
- CCEPCD
- Endo International
- Huaxin Pharmaceutical
- Jamieson
- Luitpold Pharmaceuticals
- Luitpold Pharmaceuticals (Daiichi Sankyo)
- Sanofi-Aventis
- Pfizer
- Mylan
- Merck
- Teva (Actavis)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cyanocobalamin Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cyanocobalamin Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Cyanocobalamin Injection Market by Type
- 1.3.1 Vitamins
- 1.3.2 Supplements
- 1.4 Global Cyanocobalamin Injection Market Size by Type
- 1.4.1 Global Cyanocobalamin Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cyanocobalamin Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cyanocobalamin Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cyanocobalamin Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cyanocobalamin Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cyanocobalamin Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cyanocobalamin Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cyanocobalamin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cyanocobalamin Injection Industry Trends
- 2.2 Cyanocobalamin Injection Industry Drivers
- 2.3 Cyanocobalamin Injection Industry Opportunities and Challenges
- 2.4 Cyanocobalamin Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cyanocobalamin Injection Revenue (2021-2026)
- 3.2 Global Top Players by Cyanocobalamin Injection Sales (2021-2026)
- 3.3 Global Top Players by Cyanocobalamin Injection Price (2021-2026)
- 3.4 Global Cyanocobalamin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyanocobalamin Injection Major Company Production Sites & Headquarters
- 3.6 Global Cyanocobalamin Injection Company, Product Type & Application
- 3.7 Global Cyanocobalamin Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cyanocobalamin Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cyanocobalamin Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Cyanocobalamin Injection Tier 1, Tier 2, and Tier 3
4 Cyanocobalamin Injection Regional Status and Outlook
- 4.1 Global Cyanocobalamin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cyanocobalamin Injection Historic Market Size by Region
- 4.2.1 Global Cyanocobalamin Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cyanocobalamin Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Cyanocobalamin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cyanocobalamin Injection Forecasted Market Size by Region
- 4.3.1 Global Cyanocobalamin Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cyanocobalamin Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Cyanocobalamin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyanocobalamin Injection by Application
- 5.1 Cyanocobalamin Injection Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Cyanocobalamin Injection Market Size by Application
- 5.2.1 Global Cyanocobalamin Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cyanocobalamin Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cyanocobalamin Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cyanocobalamin Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cyanocobalamin Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cyanocobalamin Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cyanocobalamin Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cyanocobalamin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 ANGELINI
- 6.1.1 ANGELINI Company Information
- 6.1.2 ANGELINI Business Overview
- 6.1.3 ANGELINI Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 ANGELINI Cyanocobalamin Injection Product Portfolio
- 6.1.5 ANGELINI Recent Developments
- 6.2 Bayer HealthCare
- 6.2.1 Bayer HealthCare Company Information
- 6.2.2 Bayer HealthCare Business Overview
- 6.2.3 Bayer HealthCare Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bayer HealthCare Cyanocobalamin Injection Product Portfolio
- 6.2.5 Bayer HealthCare Recent Developments
- 6.3 Biological E
- 6.3.1 Biological E Company Information
- 6.3.2 Biological E Business Overview
- 6.3.3 Biological E Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Biological E Cyanocobalamin Injection Product Portfolio
- 6.3.5 Biological E Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
- 6.5 CCEPCD
- 6.5.1 CCEPCD Company Information
- 6.5.2 CCEPCD Business Overview
- 6.5.3 CCEPCD Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 CCEPCD Cyanocobalamin Injection Product Portfolio
- 6.5.5 CCEPCD Recent Developments
- 6.6 Endo International
- 6.6.1 Endo International Company Information
- 6.6.2 Endo International Business Overview
- 6.6.3 Endo International Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Endo International Cyanocobalamin Injection Product Portfolio
- 6.6.5 Endo International Recent Developments
- 6.7 Huaxin Pharmaceutical
- 6.7.1 Huaxin Pharmaceutical Company Information
- 6.7.2 Huaxin Pharmaceutical Business Overview
- 6.7.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio
- 6.7.5 Huaxin Pharmaceutical Recent Developments
- 6.8 Jamieson
- 6.8.1 Jamieson Company Information
- 6.8.2 Jamieson Business Overview
- 6.8.3 Jamieson Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jamieson Cyanocobalamin Injection Product Portfolio
- 6.8.5 Jamieson Recent Developments
- 6.9 Luitpold Pharmaceuticals
- 6.9.1 Luitpold Pharmaceuticals Company Information
- 6.9.2 Luitpold Pharmaceuticals Business Overview
- 6.9.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio
- 6.9.5 Luitpold Pharmaceuticals Recent Developments
- 6.10 Luitpold Pharmaceuticals (Daiichi Sankyo)
- 6.10.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
- 6.10.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
- 6.10.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio
- 6.10.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
- 6.11 Sanofi-Aventis
- 6.11.1 Sanofi-Aventis Company Information
- 6.11.2 Sanofi-Aventis Business Overview
- 6.11.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sanofi-Aventis Cyanocobalamin Injection Product Portfolio
- 6.11.5 Sanofi-Aventis Recent Developments
- 6.12 Pfizer
- 6.12.1 Pfizer Company Information
- 6.12.2 Pfizer Business Overview
- 6.12.3 Pfizer Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Pfizer Cyanocobalamin Injection Product Portfolio
- 6.12.5 Pfizer Recent Developments
- 6.13 Mylan
- 6.13.1 Mylan Company Information
- 6.13.2 Mylan Business Overview
- 6.13.3 Mylan Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Mylan Cyanocobalamin Injection Product Portfolio
- 6.13.5 Mylan Recent Developments
- 6.14 Merck
- 6.14.1 Merck Company Information
- 6.14.2 Merck Business Overview
- 6.14.3 Merck Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Merck Cyanocobalamin Injection Product Portfolio
- 6.14.5 Merck Recent Developments
- 6.15 Teva (Actavis)
- 6.15.1 Teva (Actavis) Company Information
- 6.15.2 Teva (Actavis) Business Overview
- 6.15.3 Teva (Actavis) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Teva (Actavis) Cyanocobalamin Injection Product Portfolio
- 6.15.5 Teva (Actavis) Recent Developments
7 North America by Country
- 7.1 North America Cyanocobalamin Injection Sales by Country
- 7.1.1 North America Cyanocobalamin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cyanocobalamin Injection Sales by Country (2021-2026)
- 7.1.3 North America Cyanocobalamin Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Cyanocobalamin Injection Market Size by Country
- 7.2.1 North America Cyanocobalamin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cyanocobalamin Injection Market Size by Country (2021-2026)
- 7.2.3 North America Cyanocobalamin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cyanocobalamin Injection Sales by Country
- 8.1.1 Europe Cyanocobalamin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cyanocobalamin Injection Sales by Country (2021-2026)
- 8.1.3 Europe Cyanocobalamin Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Cyanocobalamin Injection Market Size by Country
- 8.2.1 Europe Cyanocobalamin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cyanocobalamin Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Cyanocobalamin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cyanocobalamin Injection Sales by Country
- 9.1.1 Asia-Pacific Cyanocobalamin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cyanocobalamin Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cyanocobalamin Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cyanocobalamin Injection Market Size by Country
- 9.2.1 Asia-Pacific Cyanocobalamin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cyanocobalamin Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cyanocobalamin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cyanocobalamin Injection Sales by Country
- 10.1.1 South America Cyanocobalamin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cyanocobalamin Injection Sales by Country (2021-2026)
- 10.1.3 South America Cyanocobalamin Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Cyanocobalamin Injection Market Size by Country
- 10.2.1 South America Cyanocobalamin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cyanocobalamin Injection Market Size by Country (2021-2026)
- 10.2.3 South America Cyanocobalamin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cyanocobalamin Injection Sales by Country
- 11.1.1 Middle East and Africa Cyanocobalamin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cyanocobalamin Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cyanocobalamin Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cyanocobalamin Injection Market Size by Country
- 11.2.1 Middle East and Africa Cyanocobalamin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cyanocobalamin Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cyanocobalamin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cyanocobalamin Injection Value Chain Analysis
- 12.1.1 Cyanocobalamin Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cyanocobalamin Injection Production Mode & Process
- 12.2 Cyanocobalamin Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cyanocobalamin Injection Distributors
- 12.2.3 Cyanocobalamin Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst